Andrzej Roman Batt
Ferring Pharmaceuticals
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Andrzej Roman Batt.
Bioorganic & Medicinal Chemistry Letters | 1998
Graeme Semple; Doreen M. Ashworth; Andrzej Roman Batt; Andrew John Baxter; David W.M. Benzies; Lucy H. Elliot; D.Michael Evans; Richard Jeremy Franklin; Peter Hudson; Paul D. Jenkins; Gary Robert William Pitt; David Philip Rooker; Satoshi Yamamoto; Yasuo Isomura
Pyridone-based peptidomimetic inhibitors of recombinant human Interleukin-1 beta-converting enzyme (ICE, caspase-1) with an aminomethylene ketone activating group in the P1 position are described. Several analogues with sub-nanomolar Kis versus ICE and improved aqueous solubility are reported.
Bioorganic & Medicinal Chemistry Letters | 1997
Graeme Semple; Doreen M. Ashworth; Graham R. Baker; Andrzej Roman Batt; Andrew John Baxter; David W.M. Benzies; Lucy H. Elliot; D.Michael Evans; Richard Jeremy Franklin; Peter Hudson; Paul D. Jenkins; Gary Robert William Pitt; David Philip Rooker; Andrew Sheppard; Michael Szelke; Satoshi Yamamoto; Yasuo Isomura
Abstract New potent, reversible inhibitors of recombinant human Interleukin-1β-converting enzyme (ICE, caspase-1) with significantly reduced peptide character are described. The compounds were designed by incorporation of pyridone and pyrimidone heterocyclic replacements for the P2-P3 amino acids of the native substrate and were optimised by manipulation of peripheral alkyl and aryl substituents.
Bioorganic & Medicinal Chemistry Letters | 1996
Graeme Semple; Hamish Ryder; David A. Kendrick; Andrzej Roman Batt; Elizabeth Mathews; David Philip Rooker; Michael Szelke; Akito Nishida; Keiji Miyata
Abstract The design, synthesis and biological activity of two novel series of compounds derived from the basic Boc-CCK-4 structure which provide potent ligands for the gastrin/CCK-B receptor is outlined. Within these series, new pseudopeptide compounds were discovered which unexpectedly were functional agonists in vivo, as shown by their ability to stimulate basal gastric acid secretion in rats, an effect which was blocked by the potent gastrin/CCK-B receptor antagonist YM022.
Journal of Medicinal Chemistry | 1997
Graeme Semple; Hamish Ryder; David Philip Rooker; Andrzej Roman Batt; David A. Kendrick; Michael Szelke; Mitsuaki Ohta; Masato Satoh; Akito Nishida; Shinobu Akuzawa; Keiji Miyata
Archive | 1993
Hamish Ryder; David A. Kendrick; Graeme Semple; Keiji Miyata; Andrzej Roman Batt; Elizabeth Alice Mathews; David Philip Rooker; Akito Nishida; Shinobu Azuzawa; Michael Szelke
Bioorganic & Medicinal Chemistry Letters | 2004
Gary Robert William Pitt; Andrzej Roman Batt; Robert Haigh; Andrew Penson; Peter A. Robson; David Philip Rooker; André Tartar; Julie E. Trim; Christopher M. Yea; Michael Bryan Roe
Archive | 2003
Michael Bryan Roe; Andrzej Roman Batt; David Michael Evans; Gary Robert William Pitt; David Philip Rooker
Archive | 2004
Peter Hudson; Gary Robert William Pitt; David Philip Rooker; Andrzej Roman Batt; Celine Marguerite Simone Heeney; Michael Bryan Roe
Drugs of The Future | 2006
Doreen Mary Ashworth; Andrzej Roman Batt; Andrew John Baxter; Pierre Broqua; Robert Haigh; Peter Hudson; Celine Marguerite Simone Heeney; Régent Laporte; Andrew Penson; Gary Robert William Pitt; Peter A. Robson; David Philip Rooker; André Tartar; Chris Yea; Michael Bryan Roe
Archive | 2004
Peter Hudson; Andrzej Roman Batt; Celine Marguerite Simone Heeney; Andrew John Baxter; Michael Bryan Roe; Peter A. Robson